DBD
DIEBOLD NIXDORF, Inc
NYSE · Technology · Software - Application · US
$57.42
+2.87%Year over year
Reported trailing growth
- Revenue
- +6.3%
- EBITDA
- -3.1%
- EBIT
- +19.6%
- EPS
- +56.8%
- Free cash flow
- -39.1%
- Operating cash flow
- -35.3%
Forward estimates
Based on analyst estimates
- Revenue
- +0.2%
- EBITDA
- +39.3%
- EPS
- +155.1%
Three-year CAGR
- Revenue
- +3.2%
- EBITDA
- +8.4%
- EBIT
- +96.2%
- Net income
- -73.8%
- EPS
- -65.3%
- Free cash flow
- +99.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026